Skip to main content

Table 2 Preexisting medical conditions among children admitted with seasonal influenza (2007-2009) and novel influenza A H1N1 (nH1N1) infection

From: Clinical outcomes of seasonal influenza and pandemic influenza A (H1N1) in pediatric inpatients

 

Seasonal influenza

nH1N1 influenza

p-value

None

35 (26%)

24(18%)

.14

Obesity

49 (46%)

51(45%)

1.00

Asthma

20 (15%)

40 (30%)

< .01

Sickle Cell Disease

17 (12.8%)

26 (20%)

.18

Neuromuscular Disorder

24 (18%)

9 (7%)

< .01

Diabetes Mellitus (type 1)

2 (2%)

2 (2%)

1.00

Chronic Lung Disease

15 (11%)

15 (11%)

1.00

Malignancy

13 (10%)

11(8%)

.83

Immunodeficiency ††

10 (8%)

4 (3%)

.17

Prematurity (24-37 w)

5 (4%)

10 (8%)

.29

Cardiac disorder

8 (6%)

5 (4%)

.57

Metabolic disorder

7 (5%)

7 (5%)

1.00

Renal Failure

3 (2%)

1 (1%)

.62

Cystic Fibrosis

4 (3%)

3 (2%)

1.00

  1. Body mass index ≥90%, ††HIV, solid organ transplant, immunodeficiency, corticosteroids ≥ 2 mg/kg/day for >14 days